A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor

Clinical trial NCT04797468 · WITHDRAWN

Trial details

NCT number: NCT04797468
Sponsor: Shanghai Henlius Biotech
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-07-18
Primary completion: 2023-01-13
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.